EGFR Signaling in Colorectal Carcinoma
2011

EGFR Signaling in Colorectal Carcinoma

publication Evidence: moderate

Author Information

Author(s): Alyssa M. Krasinskas

Primary Institution: University of Pittsburgh Medical Center

Hypothesis

The EGFR pathway and its impact on colorectal carcinogenesis and prognosis are the emphasis of this paper.

Conclusion

Alterations within the EGFR signaling cascade contribute to colorectal carcinogenesis and can impact prognosis.

Supporting Evidence

  • EGFR is expressed in a variety of human tumors, including colorectal cancer.
  • Mutations in the KRas gene are found in 30%–40% of colorectal cancers.
  • BRAF mutations occur in 5–22% of all colorectal cancers.

Takeaway

This study talks about how a specific protein called EGFR is important in the growth of colon cancer and how changes in this protein can affect treatment outcomes.

Limitations

The significance of EGFR protein expression in colorectal cancer remains controversial due to varying detection methods.

Digital Object Identifier (DOI)

10.4061/2011/932932

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication